You have 9 free searches left this month | for more free features.

Sustained Release

Showing 1 - 25 of 7,883

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Generalized Anxiety Disorder Trial in Beijing (Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg,

Not yet recruiting
  • Generalized Anxiety Disorder
  • Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg
  • +2 more
  • Beijing, China
    Peking University Sixth Hospital
Aug 1, 2023

Crohn's Disease, Oral Ulcer Trial in Xi'an (Mesalazine Sustained-Release Tablets, Riboflavin Sodium Phosphate Injection)

Withdrawn
  • Crohn's Disease
  • Oral Ulcer
  • Mesalazine Sustained-Release Tablets
  • Riboflavin Sodium Phosphate Injection
  • Xi'an, Shaanxi, China
    Xijing Hospital
Jan 30, 2023

Partial Seizure Trial in Tianjin (Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets

Active, not recruiting
  • Partial Seizure
  • Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Municipal People's Hospital
Jan 31, 2023

Hypertension Trial in Dongguan (Felodipine sustained release tablets (trade name: plendil®), Felodipine Controlled Release

Active, not recruiting
  • Hypertension
  • Felodipine sustained release tablets (trade name: plendil®)
  • Felodipine Controlled Release Tablets
  • Dongguan, Guangdong, China
    Clinical Trial Centre of Dongguan Kanghua Hospital
Jan 31, 2023

Oxycodone Sustained-release Tablets for Moderate to Severe

Recruiting
  • Cancer Pain
  • +2 more
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jul 24, 2023

    Pain Trial (JAN101 SR, Placebo)

    Not yet recruiting
    • Pain
    • JAN101 SR
    • Placebo
    • (no location specified)
    May 30, 2023

    Liver Transplantation Trial (Tacrolimus Sustained-release Capsules)

    Not yet recruiting
    • Liver Transplantation
    • Tacrolimus Sustained-release Capsules
    • (no location specified)
    Nov 25, 2023

    Sarpogrelate, Blood Viscosity, Peripheral Arterial Disease Trial in Uijeongbu (Sarpogrelate Sustained Release/Aspirin, Aspirin)

    Recruiting
    • Sarpogrelate
    • +3 more
    • Sarpogrelate Sustained Release/Aspirin
    • Aspirin
    • Uijeongbu, Gyeonggi-do, Korea, Republic of
      The Catholic University of Korea Uijeongbu St. Mary's Hospital
    Feb 6, 2023

    Cerebral Small Vessel Diseases Trial in Beijing (Pentoxifylline sustained-release tablets, Pentoxifylline sustained-release

    Not yet recruiting
    • Cerebral Small Vessel Diseases
    • Pentoxifylline sustained-release tablets
    • Pentoxifylline sustained-release tablets placebo
    • Beijing, China
      Beijing Tiantan Hospital
    Oct 13, 2022

    Somatic Symptom Trial in Shanghai (toludesvenlafaxine HCl sustained-release tablets)

    Not yet recruiting
    • Somatic Symptom
    • toludesvenlafaxine hydrochloride sustained-release tablets
    • Shanghai, Shanghai, China
      Shanghai Mental Health Center
    May 6, 2023

    Neuropathic Pain, Diabetes, Type 2 Trial in Korea, Republic of (pregabalin sustained release tablet, pregabalin immediate

    Active, not recruiting
    • Neuropathic Pain
    • Diabetes Mellitus, Type 2
    • pregabalin sustained release tablet
    • pregabalin immediate release capsule
    • Cheongju, Chungcheongbuk-do, Korea, Republic of
    • +7 more
    Nov 14, 2022

    Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,

    Not yet recruiting
    • Idiopathic Parkinson Disease
    • levodopa/carbidopa oral formulation A
    • +2 more
    • Minneapolis, Minnesota
      University of Minnesota
    Jul 20, 2022

    Pain, Acute, Opioid Use Trial in Edmonton (Hydromorphone)

    Recruiting
    • Pain, Acute
    • Opioid Use
    • Edmonton, Alberta, Canada
      University of Alberta Hospital
    May 12, 2022

    Renal Transplant Recipients Trial in China (Tacrolimus sustained-release capsule)

    Completed
    • Renal Transplant Recipients
    • Tacrolimus sustained-release capsule
    • Beijing, China
    • +8 more
    Jul 26, 2022

    Prostate Cancer Trial in Guangzhou (Goserelin Acetate Sustained-Release Microspheres for Injection, Zoladex 10.8 MG Drug

    Not yet recruiting
    • Prostate Cancer
    • Goserelin Acetate Sustained-Release Microspheres for Injection
    • Zoladex 10.8 MG Drug Implant
    • Guangzhou, China
      Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    May 3, 2023

    Idiopathic Pulmonary Fibrosis Trial in Cincinnati (Esbriet 267 MG Oral Capsule, EXCL-100, 600 MG Oral Tablet)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Esbriet 267 MG Oral Capsule
    • EXCL-100, 600 MG Oral Tablet
    • (no location specified)
    Jun 24, 2022

    Huntington Disease, Tardive Dyskinesia Trial in Shanghai (LPM3770164 sustained release tablet, LPM3770164 sustained release

    Not yet recruiting
    • Huntington Disease
    • Tardive Dyskinesia
    • LPM3770164 sustained release tablet
    • LPM3770164 sustained release tablet simulant
    • Shanghai, Shanghai, China
      Shanghai Mental Health Center
    Feb 3, 2022

    MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)

    Not yet recruiting
    • Major Depressive Disorder
    • Toludesvenlafaxine hydrochloride sustained-release tablets
    • Shanghai, Shanghai, China
      Shanghai Mental Health Center
    Sep 7, 2023

    MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)

    Recruiting
    • Major Depressive Disorder
    • Toludivenlafaxine hydrochloride sustained-release tablets
    • Shanghai, Shanghai, China
      Shanghai Mental Health Center
    Jun 14, 2023

    Chronic Pain Trial (ST-01, 1% Lidocaine HCL)

    Not yet recruiting
    • Chronic Pain
    • (no location specified)
    Jan 27, 2023

    Preterm Birth Trial (Progesterone Sustained-release vaginal gel)

    Not yet recruiting
    • Preterm Birth
    • Progesterone Sustained-release vaginal gel
    • (no location specified)
    Mar 15, 2023

    Attention Deficit Disorder, ADHD Trial in Culver City (Centanafadine SR)

    Completed
    • Attention Deficit Disorder
    • Attention Deficit Hyperactivity Disorder
    • Centanafadine SR
    • Culver City, California
      For additional information regarding sites, contact 844-687-8522
    Apr 1, 2022

    Cocaine Use Disorder Trial in Lexington (Sustained Release d-amphetamine, Money)

    Recruiting
    • Cocaine Use Disorder
    • Sustained Release d-amphetamine
    • Money
    • Lexington, Kentucky
      Laboratory of Human Behavioral Pharmacology
    Jan 25, 2023

    Tension-Type Headache Trial in Rawalpindi (sustained natural apophyseal glides (SNAGS), suboccipital muscle release,

    Active, not recruiting
    • Tension-Type Headache
    • sustained natural apophyseal glides (SNAGS)
    • +2 more
    • Rawalpindi, Punjab, Pakistan
      Fauji Foundation Hospital
    May 22, 2023